MDV-3100 - CAS# 915087-33-1 60135 918633-87-1

918633-87-1

Targeting the multiple myeloma hypoxic niche with TH-302

Class III receptor tyrosine kinase inhibitor AC220 selectively inhibits class III receptor tyrosine kinases

Molecular Weight: 1415

genome replication

MDV-3100 - CAS# 915087-33-1 60135 918633-87-1Enzalutamide, also known as MDV3100, CAS No. 915087 33 1, is an orally bioavailable, organic, non steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, selective androgen receptor modulator MDV3100 inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation